Published in Transplantation on August 15, 2010
Association of human leukocyte antigen donor-recipient matching and pediatric heart transplant graft survival. Circ Heart Fail (2014) 0.89
Disparities, race/ethnicity and access to pediatric kidney transplantation. Curr Opin Nephrol Hypertens (2013) 0.88
Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy. J Immunol Res (2014) 0.86
Inferior allograft outcomes in adolescent recipients of renal transplants from ideal deceased donors. Ann Surg (2012) 0.85
Posttransplant lymphoproliferative disease after pediatric solid organ transplantation. Clin Dev Immunol (2013) 0.83
Malignancies after pediatric kidney transplantation: more than PTLD? Pediatr Nephrol (2013) 0.78
Use of pharmacogenomics in pediatric renal transplant recipients. Front Genet (2015) 0.78
HLA sensitisation: can it be prevented? Pediatr Nephrol (2014) 0.78
Are there good reasons for inequalities in access to renal transplantation in children? Nephrol Dial Transplant (2014) 0.75
Does graft mass impact on pediatric kidney transplant outcomes? Pediatr Nephrol (2014) 0.75
Kidney Donor Profile Index Does Not Accurately Predict the Graft Survival of Pediatric Deceased Donor Kidneys. Transplantation (2016) 0.75
Pediatric organ allocation: matching tissue and needs. Transplantation (2010) 0.75
HLA Mismatching Strategies for Solid Organ Transplantation - A Balancing Act. Front Immunol (2016) 0.75
Kidney retransplantation in children following rejection and recurrent disease. Pediatr Nephrol (2016) 0.75
Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med (2007) 5.31
Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant (2004) 3.25
Multicenter analysis of kidney preservation. Transplantation (2007) 2.39
C3 polymorphisms and allograft outcome in renal transplantation. N Engl J Med (2009) 2.29
Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers. Transplantation (2014) 1.96
H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet (2008) 1.85
Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant (2005) 1.78
The effect of donor gender on graft survival. J Am Soc Nephrol (2002) 1.72
No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report. Transplantation (2011) 1.67
Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis. Lancet Oncol (2007) 1.51
Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too. Transplantation (2002) 1.48
Impact of HLA compatibility on lung transplant survival and evidence for an HLA restriction phenomenon: a collaborative transplant study report. Transplantation (2010) 1.42
Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation (2013) 1.36
Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant (2005) 1.18
Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients. Transplantation (2006) 1.11
Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers. Transplantation (2015) 1.05
No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol (2006) 1.05
Influence of time of rejection on long-term graft survival in renal transplantation. Transplantation (2008) 1.04
Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation (2007) 1.03
Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes. J Am Soc Nephrol (2008) 1.02
Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma. Transplantation (2009) 1.02
Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report. Am J Transplant (2004) 1.01
Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant. Transplantation (2008) 1.00
Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. Transplantation (2009) 0.99
Inosine monophosphate dehydrogenase polymorphisms and renal allograft outcome. Transplantation (2012) 0.99
Donor ABCB1 variant associates with increased risk for kidney allograft failure. J Am Soc Nephrol (2012) 0.98
Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum Immunol (2009) 0.93
HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: a collaborative transplant study report. Transplantation (2009) 0.91
Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation. Transplantation (2010) 0.89
HLA matching and kidney transplantation: beyond graft survival. Clin Transpl (2013) 0.88
Genotypic diversity of complement component C4 does not predict kidney transplant outcome. J Am Soc Nephrol (2010) 0.86
Risks of allogeneic hand transplantation. Microsurgery (2004) 0.84
Increased pretransplantation plasma kynurenine levels do not protect from but predict acute kidney allograft rejection. Hum Immunol (2010) 0.83
Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing. Transplantation (2015) 0.82
The collaborative transplant study registry. Transplant Rev (Orlando) (2013) 0.81
Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft. Clin J Am Soc Nephrol (2010) 0.81
Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol (2002) 0.81
Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study. Hum Immunol (2009) 0.81
VEGF 936 C/T gene polymorphism in renal transplant recipients: association of the T allele with good graft outcome. Hum Immunol (2007) 0.80
Soluble CD30 as a predictor of kidney graft outcome. Transplantation (2002) 0.79
Posttransplant sCD30 as a predictor of kidney graft outcome. Transplantation (2011) 0.79
Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. Blood (2010) 0.79
Influence of Current and Previous Smoking on Cancer and Mortality After Kidney Transplantation. Transplantation (2016) 0.78
Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients. Transplantation (2011) 0.78
Deleterious impact of HLA-DRB1 allele mismatch in sensitized recipients of kidney retransplants. Transplantation (2013) 0.77
Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants. Transplantation (2011) 0.77
Reduced rate of cardiovascular death after cytomegalovirus prophylaxis in renal transplant recipients. Transplantation (2015) 0.77
Does borderline kidney allograft rejection always require treatment? Transplantation (2010) 0.76
The role of pretransplant dialysis modality on renal allograft outcome. Nephrol Dial Transplant (2011) 0.76
Renin-Angiotensin system blockers and cardiovascular death in kidney recipients. Transplantation (2014) 0.75
Response to A reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation. Transplantation (2015) 0.75
HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well Matched Deceased Donor Transplants. Transplantation (2017) 0.75
High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer. Transplantation (2017) 0.75
Genetic polymorphisms of adhesion molecules and kidney transplant survival. Transplantation (2010) 0.75
Association of pretransplant soluble glycoprotein 130 (sgp130) plasma levels and posttransplant acute tubular necrosis in renal transplant recipients. Transplantation (2009) 0.75
Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience. Nephrol Dial Transplant (2012) 0.75
Association of single nucleotide polymorphisms on chromosome 9p21.3 with cardiovascular death in kidney transplant recipients. Transplantation (2013) 0.75